In Treatment of Bacterial infections Azyrise O 500mg/400mg Capsule is an antibiotic medicine prescribed to treat various bacterial infections like sinus infections (sinusitis), chest infections such as bronchitis and pneumonia, gonorrhea (a sexually transmitted disease), and infections of the ears, skin, throat, stomach, urinary tract, and prostate gland. It works by stopping the growth of bacteria causing infection. This further reduces the discomforts associated with various infections and helps in early recovery. Make sure you complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
It is unsafe to consume alcohol with Azyrise O 500mg/400mg Capsule.
Azyrise O 500mg/400mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Azyrise O 500mg/400mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Azyrise O 500mg/400mg Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Azyrise O 500mg/400mg Capsule should be used with caution in patients with kidney disease. Dose adjustment of Azyrise O 500mg/400mg Capsule may be needed. Please consult your doctor.
Azyrise O 500mg/400mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Azyrise O 500mg/400mg Capsule may be needed. Please consult your doctor.
If you miss a dose of Azyrise O 500mg/400mg Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Indoco Remedies Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alkem Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: RPG Life Sciences Ltd || ₹14.5/tablet (25% cheaper)